The solution of the problem of congenital infections as a method to reduce infantile mortality
|
|
- Karin Fowler
- 5 years ago
- Views:
Transcription
1 The solution of the problem of congenital infections as a method to reduce infantile mortality Valeriy V. Vasilyev Professor of the Chair of Infection diseases at North-Western State University n. a. I.I. Mechnikov, Saint Petersburg
2 Mortality: CI s outcomes - Toxoplasmosis 12 % - HSV infection up to 90 % - Enteroviruses around 80 % - Parvovirus B19V to 25 % - CRS (SASPE) 100 % Nonfatal outcomes: Severe malformations Multiple organic pathology Disability Unapparent CI: Relapse of infection (toxoplasmic eye lesions in adolescents)
3 CI s burden «The estimated disease burden of congenital toxoplasmosis in the Netherlands is similar to that for salmonellosis» (Havelaar A. A H. et al. Clin. Infect. Dis. 2007) «A total of 777 congenital CMV-associated deaths occurred over the 17-year study period resulting in 56,355 years of age- adjusted years of potential life lost. 71.7% of congenital CMV-associated deaths occurred in age less than 1 year» (Bristow B.N. et al. PLoS Negl. Trop. Dis. 2011)
4 CI s economics Direct medical costs for 45 cases of CRS (occurred during two years in Brasil) were US dollars in the first year of follow-up. Indirect costs are 2-4 times higher direct ones. (Lanzieri T.M. T. et al. Pediatr Infect Dis J. J 2004) One case costs about US dollars (in 2003) in the FIRST year About 400 cases of CRS in RF annually (in «Epidemiological surveillance of congenital rubella» PD # ) Estimated DMC for expected cases of CRS in RF: 400 x = US$ (about( rubles) in the FIRST year!!!
5 Treatment in infants It is very difficult because of: Non-specific manifestations of CI Limited spectrum of agent-specific medicines Severity of pathology already persisting at the birth (often( acute phase ends already in uterus!) Very high cost (intensive care, follow-up and so on)
6 To treat or to prevent? Anti-Rubella vaccination for one woman costs about 350 rubles About 20% of pregnant women (PW) are negative for Ig G About pregnancies occur in our city annually: PW are at risk of Rubella infection To vaccinate them = rubles. ONLY ONE TIME and FOREVER!
7 Only two of many aspects in CIs prophylaxis Basic information for women Specialist s competency
8 Basic information for women THEY NEED TO BE MUCH MORE INFORMED THAN NOW!!! Family School,, college, university Each visit to maternity welfare clinics (wallpapers not only about contraception and child nutrition, but CIs and its prevention) from the first one Mass-media!!!
9 Specialist s competency (present time) The greater part of physicians DO need modern knowledge and practice in ID and CIs
10 Recommended CI s risk estimation before pregnancy (the first step = to get maximum primary information) Anamnesis and clinical data First visit Other medical records and data Sexual life, social status STD? If YES, when? What was the control? Rubella? When? Confirmed or not? Did you have such diagnoses as toxoplasmosis, CMV and others? HSV? What about partners, child s father? Physical exam s data Certificate of vaccinations Does vaccination comply with National schedule? Extra-vaccinations? Tested for HIV? When? Results? Syphilis? When? Results? Hepatites? When? Results? Something else How we have to use that information in order to estimate risks of CIs?
11 The second step = primary tests (routine and additional) Routine tests (rubella, HB, HC, HIV, syphilis serum, vaginal and cervical smears) Additional tests More than one smear At least 3 times Microcsopy PCR Immunohistochemical analyses Early beginning of sexual life, combined with low social status and income; many partners; unprotected sex; STD in anamnesis At least: serum toxoplasma, HSV, CMV, parvovirus B19V. Ig G, Ig M quantitative analyses only! If toxoplasmic Ig G was present no test HSV, CMV PCR (blood and smears) If HSV infection is relapsing If there wasn t any tests for CI recently If there are pets or children (day care centre) at home Specialists HIV infected HBV, HCV infected Syphilis was documented
12 Dynamics of anti-toxoplasmic Ig (type 1) % экстинции; МЕ/мл Ig M-tox Ig G-tox cut-off Ig M до 8 недель 9-16 недель недель недели недели недели позже 52 недели От начала заболевания
13 The third step = primary risk s estimation after primary tests results Routine tests (rubella, HB, HC, HIV, syphilis serum, vaginal and cervical smear) HIV, HBV, HBC, syphilis positive Specialists Information: Risk of acute infections How to prevent Re-testing after consumption Additional tests No signs of infections, antibodies are absent HIV, HBV, HBC, syphilis, OSTD negative Repeat tests after consumption NO risk! Toxoplasmic Ig G + Ig M - negative Rubella negative Rubella positive STD positive Vaccinate AFAP! Only Ig G NO risk Ig M re-test To treat and control Treatment, control Delay of pregnancy Risk of CIs is low Signs of acute or Signs of acute or relapsed other relapsed infections infections Latent infections at present time
14 Further activities If woman is well-examined, well-treated and well- controlled and so has no (or low) risks of CIs before consumption, we may use only routine examinations during pregnancy In other cases see steps 1 and 2, at first, then next picture
15 The third step for pregnant women Routine tests (rubella, HB, HC, HIV, syphilis serum, vaginal and cervical smear) HIV, HBV, HBC, syphilis positive Specialists Information: Risk of acute infections How to prevent Monitoring Additional tests No signs of infections, antibodies are absent HIV, HBV, HBC, syphilis, STD negative Repeat tests as recommended NO risk? Toxoplasmic Ig G + Ig M - negative Rubella negative Rubella positive Avoid exposure Monitoring Only Ig G NO risk If Ig M: re-test, Repeat estimation Monitoring? To treat and control Risk of CIs is low? Monitoring is expensive Signs of acute or Signs of acute or relapsed other relapsed infections infections Latent infections at present time STD positive To treat and control Is that simply and easy?
16 Clinical case 28 y.o. immunocompetent woman. First exam at 8 th week of gestation: specific Ig M to T. gondii - positive, «high» levels of Ig G. Tests were repeated EVERY week (Ig M positive,, Ig G at the same levels). Quantitative Q test for Ig M was never conducted. Ig G avidity was less than 30%. PCR negative (blood, 3 times). There were not antibodies 3 years before. Spiramycine from 12 th week,, the advice to cease pregnancy (3 times). Exam in RSI of children s infections at 15 weeks of gestation: quantitative test for Ig M positive (1, 95; cut-off = 0,85), Ig G = 98 IU/ml (cut-off -= 4). Ig G avidity = 42 %. No signs of acute toxoplasmosis. Fetus USE normal. Conclusion: acute acquired toxoplasmosis with exposure at early pregnancy WITHOUT vertical transmission. Unfortunately, patient had received this information too late (returning to home city, woman had visited specialists, which really forced her to cease pregnancy ) Those specialists don t know,, that the vertical transmission s risk T. gondii- infection in first trimester is around 6%, but if occurs it will be abortion in 99,999 % of cases before 2 nd trimester.. Woman had normal pregnancy up to 16 th week
17 Improving specialists competency Training under control of specialists in ID!!! How? The Chair of Infectious Diseases of Northern- West State Medical University n. a. I.I. Mechnikov (Saint-Petersburg, RF) offers short-term (two weeks) theoretical and practice training in CI from For all specialists!
18 Possible key directions toward better CIs prevention More information for women (motivate to be examined before pregnancy) Education for all specialists who have bearing on this situation Expanding spectrum of tests (social insurance) More real dates and recommendations for motoring during pregnancy Use modern methods (quantitative analyses only)
19 Thank you very much for attention!
Bio-Rad Laboratories. The Best Protection Whoever You Are. Congenital and Pediatric Disease Testing
Bio-Rad Laboratories I N F E C T I O U S D I S E A S E T E S T I N G The Best Protection Whoever You Are Congenital and Pediatric Disease Testing Bio-Rad Laboratories I N F E C T I O U S D I S E A S E
More informationManagement of Viral Infection during Pregnancy
Vaccination Management of Viral Infection during Pregnancy JMAJ 45(2): 69 74, 2002 Takashi KAWANA Professor of Obstetrics and Gynecology, Teikyo University Mizonokuchi Hospital Abstract: Viral infection
More informationLecture-7- Hazem Al-Khafaji 2016
TOXOPLASMOSIS Lecture-7- Hazem Al-Khafaji 2016 TOXOPLASMOSIS It is a disease caused by Toxoplasma gondii which is a protozoan parasite that is infects a variety of mammals and birds throughout the world.
More informationReliable screening for early diagnosis
Elecsys TORCH panel Reliable screening for early diagnosis Toxoplasmosis Rubella HSV CMV Toxoplasmosis The safe and sure approach to Toxo screening Ultrasensitive Toxo IgM optimized to detect all potential
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on
More informationCHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE
CHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE What are sexually transmitted diseases (STDs)? Sexually transmitted diseases (STDs) are passed from person to person through sexual activity. These infections
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationUnderstanding Preventive Care
Understanding Preventive Care FAQs: Understanding Preventive Care At Blue Cross and Blue Shield of Vermont, (BCBSVT) we want you to get preventive care so you can find out about health problems early and
More informationMichigan Guidelines: HIV, Syphilis, HBV in Pregnancy
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy Presenter: Theodore B. Jones, MD Maternal Fetal Medicine Wayne State University School of Medicine Beaumont Dearborn Hospital HIV, Syphilis, HBV in
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationNon-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique
More informationThe Study of Congenital Infections. A/Prof. William Rawlinson Dr. Sian Munro
The Study of Congenital Infections A/Prof. William Rawlinson Dr. Sian Munro Current Studies SCIP Study of Cytomegalovirus (CMV) Infection in Pregnancy ASCI Amniotic Fluid Study of Congenital Infections
More informationAnswering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa
Answering your daily challenges in the ELISA technology I N FECTI OUS DISEASES bioelisa RETROVIRUS HIV is the cause of the most important global pandemic. Due to the lack of vaccination, early diagnosis
More informationNon-reproductive tissues and cells
Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not
More informationEC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK
National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on
More informationGuidelines on safer conception in fertile HIV infected individuals
Guidelines on safer conception in fertile HIV infected individuals couples Vivian Black Co-authors: L-G Bekker, H Rees, S Black, D Cooper, S Mall, C Mnyami, F Conradie, I Mahabeer, L Gilbert, S Schwartz,
More informationThe problem with TORCH screening
: Beyond TORCHeS TORCH or STORCH-a helpful mnemonic? Toxoplasma Other Rubella CMV HSV (HIV) Syphilis 3 The problem with TORCH screening TORCH-first proposed by Nahmias et.al. (Pediatr Res 1971) Toxo, Rubella,
More information1. Which of the following is an addition to components of reproductive health under the new paradigm
Population Change and Public Health Exercise 11A 1. Which of the following is an addition to components of reproductive health under the new paradigm A. Safe motherhood B. Provision of family planning
More informationYakima Health District BULLETIN
Yakima Health District BULLETIN Volume 12, Issue 4 December, 2013 Overview Prevention of Perinatal Hepatitis B Transmission Perinatal transmission of hepatitis B virus (HBV) is preventable through universal
More informationAppendix 1: summary of the modified GRADE system (grades 1A 2D)
Appendix 1: summary of the modified GRADE system (grades 1A 2D) 1A 1B 1C 1D 2A 2B 2C 2D Strong recommendation High-quality evidence Benefits clearly outweigh risk and burdens, or vice versa Consistent
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More informationCHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE
CHLAMYDIA, GONORRHEA & SYPHILIS: STDS ON THE RISE What are sexually transmitted diseases (STDs)? Sexually transmitted diseases (STDs) are passed from person to person through sexual activity. These infections
More informationCytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy
Infectious Disease Cytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy FOR OUTSIDE THE US AND CANADA ONLY Confidence in Your Results LIAISON Cytomegalovirus
More informationZika Virus. Robert Wittler, MD
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationZika Virus. Disclosure. Zika Virus 8/26/2016
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationWang Linhong, Deputy Director, Professor National Center for Women and Children s Health, China CDC
Maternal and Child Health in China Wang Linhong, Deputy Director, Professor National Center for Women and Children s Health, China CDC Table of Contents 1 MCH Development and Situation in China 2 MCH Resources
More informationNon-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recomd on national level Not legy binding and not recomd
More informationin pregnancy Document Review History Version Review Date Reviewed By Approved By
GYNAECOLOGY/ ANTENATAL CARE WIRRAL WOMEN & CHILDREN S HOSPITAL Guideline No: Hepatitis B management in pregnancy VERSION 1 AMENDMENTS MADE: N/A DATE OF ISSUE: May 2012 DATE OF REVIEW: May 2015 REVIEW INTERVAL:
More informationInjury Chronic Disease Infant Mortality Maternal & Child Health Infectious Disease Life Expectancy
Visit WatchUsThrive.org to learn more Welcome to the Community Health Pathway of WeTHRIVE! SM Here you will find a brief Community Health Assessment for your community. This will provide you with health
More informationShould we treat hepatitis B positive pregnant women to prevent mother to child transmission?
Should we treat hepatitis B positive pregnant women to prevent mother to child transmission? Daniel Shouval Liver Unit Hadassah-Hebrew University Hospital Jerusalem, Israel VHPB Vienna June 1-2, 2017 Background
More informationSEX AND SEXUALLY TRANSMITTED INFECTIONS
SEX AND SEXUALLY TRANSMITTED INFECTIONS Sex and STIs Be fully informed, Be safe! Prevent Pregnancy Practice abstinence Use effective birth control Use Emergency Contraception Prevent STI s Practice Abstinence
More informationToxoplasma gondii. Jarmila Kliescikova, MD 1. LF UK
Toxoplasma gondii Jarmila Kliescikova, MD 1. LF UK Toxoplasma gondii Apicomplexa, Koccidia Obligate intracellular parasite Distribution: cosmopolite Transmission: alimentary transplacentary (transfusions,
More informationTrends in Reportable Sexually Transmitted Diseases in the United States, 2007
Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis Sexually transmitted diseases (STDs) remain a major public
More informationHow to recognise a congenitally infected fetus? Dr. Amar Bhide Consultant in Obstetrics and Fetal Medicine
How to recognise a congenitally infected fetus? Dr. Amar Bhide Consultant in Obstetrics and Fetal Medicine Scope Cytomegalovirus Parvovirus Varicella Toxoplasma Rubella Clinical scenarios Maternal exposure
More informationINTERNATIONAL JOURNAL CEUTICAL RESEARCH AND
Research Article CODEN: IJPRNK B. V. Ramana, IJPRBS, 2013; Volume 2(4): 253-258 ISSN: 2277-8713 IJPRBS INTERNATIONAL JOURNAL OF PHARMAC CEUTICAL RESEARCH AND BIO-SCIENCE SEROPREVALENCE OF ACUTE TOXOPLASMOSIS
More informationSTD PREVENTION FOR WOMEN, YOUTH AND TRANSGENDER PERSONS
STD PREVENTION FOR WOMEN, YOUTH AND TRANSGENDER PERSONS IN SAN FRANCISCO Susan Philip MD MPH Disease Prevention and Control Branch Population Health Division San Francisco Health Commission June 20, 2017
More informationPERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases
PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases Viruses in July (ViJ), 2004 Overview Epidemiology Perinatal transmission
More informationAsk at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?
Essential Sexual Health Questions to Ask Adults Ask all of your adult patients the sexual health questions on this card. They will help you assess the patient s level of sexual risk and determine whether
More informationNon-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Non-reproductive tissues and cells VIRAL
More informationZika Virus What Every Woman Needs to Know
Zika Virus What Every Woman Needs to Know Carrie L. Byington, MD The Jean and Thomas McMullin Professor and Dean of Medicine Senior Vice President Health Science Center Vice Chancellor for Health Services
More informationOB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program
OB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program Dear Colleague, This letter is to introduce myself and explain the role I play with the Alaska Perinatal Hepatitis B Program. Alaska
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More informationZika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS
Zika: Deet, There It Is Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS Disclosure I have no financial disclosures or conflicts of interest Lessons from Rubella At peak of rubella epidemic
More informationMultnomah County Health Department. Report Card on Racial and Ethnic Health Disparities. April 2011
Multnomah County Health Department Report Card on Racial and Ethnic Health Disparities April 2011 Lillian Shirley, Director, Multnomah County Health Department Sandy Johnson, Office of Health and Social
More informationAdolescent HPV Prevalence Survey
November 2004 Page 1 of 7 Adolescent HPV Prevalence Survey FOLLOW-UP QUESTIONNAIRE Family/Given Name Initials HPV U Study number Study number OS/IN NTIHC number Date of Interview: Date first seen: (dd/mm/yy)
More informationGLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding
More informationSexual & Reproductive Health in the Context of Zika Virus
Contents 1 The Zika Epidemic & its Impact on Health 2 Transmission, Pregnancy & Human Rights 3 GTR s Program & Public Policy Recommendations 4 GTR's Recommendations for Health Care Providers 5 GTR's Sexual
More informationPregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20
Introduction Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20 Proportions HIV infections 19% amongst adolescents (- 29.5% nationally 15
More informationTable of Contents INTRODUCTION... 2 METHODOLOGY Appendix 1 Comparison of Peer Counties... 6
Table of Contents INTRODUCTION... 2 METHODOLOGY... 4 Appendix 1 Comparison of... 6 Appendix 2 Key Findings from the MAPP Assessments... 7 BARRIERS TO HEALTHCARE ACCESS... 7 HEALTH STATUS... 9 DEATH INDICATORS...
More informationEAST LONDON INTEGRATED CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationObstetric Complications in HIV-Infected Women. Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School
Obstetric Complications in HIV-Infected Women Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School Obstetric Complications and HIV Obstetric complications are not increased in
More informationCenters for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,
Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, 20001 202-777-2514 Donald Hoppert, Director of Government Relations, American
More informationEpidemiology of blood-borne Infections in Vietnam
IPFA 4 th Asia Workshop on Plasma Quality and Supply Epidemiology of blood-borne Infections in Vietnam Nguyen Thị Lan Anh MD, PhD Center for Bio-Medical Rsearch Screening donated blood for infections:
More informationThe Impact of Sexually Transmitted Diseases(STD) on Women
The Impact of Sexually Transmitted Diseases(STD) on Women GAL Community Symposium AUM September 2, 2011 Agnes Oberkor, MPH, MSN, CRNP, Nurse Practitioner Senior Alabama Department of Public Health STD
More informationControls & Calibrators. Disease Quality Controls
Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted
More information26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges
Rate per, Types of Viral Hepatitis A E B D C Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Source of virus Feces Feces Blood/bloodderived body fluids
More informationMicrobes at Our Doorstep: Emerging issues in infection control and travel-related infections
Microbes at Our Doorstep: Emerging issues in infection control and travel-related infections Peel November 2, 2016 Learning Objectives At the end of this session, participants will be able to: 1. Identify
More informationQuestions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection
1 of 5 01/02/2016 20:39 Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection Summary CDC has developed interim guidelines for healthcare providers in the United States
More informationTOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV
TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV Gladwel Muthoni KPA Conference 24 th April, 2018 OUTLINE Burden of HIV in PMTCT Mechanism and timing of Mother to Child Transmission (MTCT) Four
More informationClick to edit Master title style. Unintended Pregnancy: Prevalence. Unintended Pregnancy: Risk Groups. Unintended Pregnancy: Consequences 9/23/2015
The Role of Childhood Violence, Self-esteem and Depressive Symptoms on Inconsistent Contraception Use among Young, Sexually Active Women Deborah B. Nelson, PhD Associate Professor Unintended Pregnancy:
More informationTable for Identifying Knowledge Gaps for Use in the World Report on Knowledge for Better Health
Table for Identifying Knowledge Gaps for Use in the World Report on Knowledge for Better Health Types of knowledge needed Maternal and Newborn Health Family Planning Unsafe abortion RTI/STIs New knowledge
More informationACA first-dollar coverage for preventive services
I N F O R M A T I O N U P D A T E September 2014 ACA first-dollar coverage for preventive services The Affordable Care Act (ACA) mandates that all non-grandfathered group and individual health plans must
More informationUse of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH
Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH University of Pittsburgh Medical Center Disclosures Presenter has no financial interests to
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationHepatitis and pregnancy
Hepatitis and pregnancy Pierre-Jean Malè MD Training Course in Reproductive Health Research WHO Geneva 2008 26.02.2008 Liver disease and pregnancy: three possible etiologic relationship the patient has
More informationCOMMUNICABLE DISEASE REPORT
June 2011 Department of Health and Community Services Government of Newfoundland and Labrador COMMUNICABLE DISEASE REPORT Reporting Sexually Transmitted and Bloodborne Infections All laboratory-confirmed
More informationPreventive Services Reference Guide for Members 2018
Preventive Services Reference Guide for Members 2018 Together with Children s Community Health Plan (CCHP) covers many preventive services at no cost to you, including screening tests and immunizations
More informationTunisian recommendations on ART : process and results
Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN
More informationImmunization Updates & Collaborative Projects: Working Together to Protect Moms & Babies. Rebeca Boyte, MAS, CLEC
Immunization Updates & Collaborative Projects: Working Together to Protect Moms & Babies Rebeca Boyte, MAS, CLEC Message from STD Branch: Think SYPHILIS! It s on the rise and it s serious. 500% increase
More informationNEW YORK STATE TEAMSTERS COUNCIL HEALTH & HOSPITAL FUND APPENDIX A SCHEDULE OF BENEFITS SUPREME BENEFITS
BENEFIT GUIDE NEW YORK STATE TEAMSTERS COUNCIL HEALTH & HOSPITAL FUND APPENDIX A SCHEDULE OF SUPREME IN NETWORK FEATURES Primary Care Physician Not Required 2 Physician Referrals Not Required 2 Out of
More informationHealth, Labor and Welfare in Japan
Countermeasures against Congenital Toxoplasmosis and Cytomegalovirus Infection Led by the Research Team* under the Supervision of the Ministry of Health, Labor and Welfare in Japan *Tomoyuki Fujii (Leader),
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More informationSexually Transmitted Infections
Sexually Transmitted Infections Introduction Sexually transmitted diseases, or STDs, are some of the most common infectious diseases. Sexually transmitted diseases are also called sexually transmitted
More informationSpreading the CMV Message: the Who, How, What, and When. Alyson Ward M.S. CHES, IA Sara Doutré M.A.
+ Spreading the CMV Message: the Who, How, What, and When Alyson Ward M.S. CHES, IA Sara Doutré M.A. + Agenda n What is CMV n Lack of Awareness n CMV Messaging n Small Workgroups n Sharing +What is CMV:
More informationFertility Management in HIV. INTEREST Workshop, 16 Dakar May 2013 Vivian Black, Director Clinical Programmes Wits Reproductive Health & HIV Institute
Fertility Management in HIV INTEREST Workshop, 16 Dakar May 2013 Vivian Black, Director Clinical Programmes Wits Reproductive Health & HIV Institute What to consider Does HIV affect fertility success?
More informationFrozen Donor Embryo Transfer Price List, EDI 2017
Frozen Donor Embryo Transfer Price List, EDI 2017 Introduction: We have done our best to be accurate in estimating your fees. If you have had some of these tests completed relatively recently, they will
More informationPerinatal Hepatitis b Prevention
Perinatal Hepatitis b Prevention Purpose 2 The primary goal of the Perinatal Hepatitis b Prevention Program (PHBPP) is to identify all pregnant women who are infected with hepatitis b and prevent perinatal
More informationWorld Bank Group Medical Benefits Plan (MBP) A Guide to Preventive Care Effective 2015
World Bank Group Medical Benefits Plan (MBP) A Guide to Preventive Care Effective The Bank Group s Medical Benefits Plan (MBP), Continuation Medical Benefits Plan (CMBP) and Retiree Medical Benefits Plan
More informationViral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a
Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes
More informationWomen have unique health issues and some of the health issues that affect both men and women can affect women differently.
Woman s Health Women have unique health issues and some of the health issues that affect both men and women can affect women differently. Some unique issues include pregnancy, menopause, and conditions
More informationGENITAL HERPES. 81.1% of HSV-2 infections are asymptomatic or unrecognized. Figure 14 HSV-2 seroprevalence among persons aged years by sex.
GENITAL HERPES Genital herpes is a chronic, lifelong, sexually transmitted disease caused by herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). HSV-1 typically causes small, painful, fluid-filled,
More information9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before
George Walton, MPH, CPH, MLS(ASCP) CM STD Program Manager Bureau of HIV, STD, and Hepatitis September 15, 2015 1 1) Discuss the changing epidemiology of syphilis in Iowa; 2) Explore key populations affected
More informationCITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationHepatitis B at a Glance
Return completed form, preferably within 30 days of U.S. date of arrival, to address on reverse side of this form. Review overseas medical exam if available and document immunization dates. Indicate if
More informationCommunity Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital
Community Genetics Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital Training Course in Sexual and Reproductive Health Research Geneva 2011 Definition of Community Genetics
More informationWe are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference
NEWS BK NEWS# 390/ MKT DATE : 13-07-2016 TITLE : New Leaflet bioelisa Menu and Instrumentation Dear colleagues, We are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference
More informationInnovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationUses and Misuses of Viral Hepatitis Testing. Origins of Liver Science
Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness
More informationPre-exposure Prophylaxis for HIV Prevention
Mountain West AIDS Education and Training Center Pre-exposure Prophylaxis for HIV Prevention Concerns about PrEP: Sexual Behavior and STIs Joanne Stekler, MD MPH May 19, 2016 This presentation is intended
More informationPreventive care services for commercial members
Preventive care services for commercial members This schedule is a reference tool for planning your preventive care, and lists items/services covered under the Patient Protection and Affordable Care Act
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationHPV Vaccination. Dr. Vivien Tsu PATH. HPV Vaccination 1
HPV Vaccination Dr. Vivien Tsu PATH HPV Vaccination 1 HPV vaccine overview 1 First vaccines to focus on a female cancer. Prepared from virus-like particles (VLPs). VLPs are non-infectious. Two vaccines
More informationProgress in Human Reproduction Research. UNDP/UNFPA/WHO/World Bank. (1) Who s Work in Reproductive Health: The Role of the Special Program
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Developemnt and Research Training in Human Reproductive (HRP). WHO's work in reproductive health: the role of the Special Programme. Progress in
More informationWhat?! Why?! Emergency Contraception. physical consequences. emotional consequences
HealthCHAT Emergency Contraception What?! Emergency contraception is a series of pills that can be taken by a woman to prevent pregnancy after having unprotected sex. Why?! Emergency contraception allows
More informationPREVENTIVE HEALTH GUIDELINES
PREVENTIVE HEALTH GUIDELINES As of May 2016 What is your plan for better health? Make this year your best year for wellness. Your health plan may help pay for tests to find disease early and routine wellness
More informationWelcome to 4 th Syphilis Report to the Community. May 18, 2016
Welcome to 4 th Syphilis Report to the Community May 18, 2016 Syphilis and STDs in Bexar County Anil T. Mangla, MS, PhD, MPH, FRIPH Assistant Director of Health Syphilis Update to the Community May 18,
More information